Holdings

First Trust Health Care AlphaDEX Fund

As of Jul 31, 2026, First Trust Health Care AlphaDEX Fund reported 73 positions worth US$1.05B. Largest: Regeneron Pharmaceuticals, Inc., Universal Health Services, Inc. and Solventum Corporation. What it bought and sold, with each filing.

Holdings

Part of
First Trust
Positions
73
Value as reported
US$1.05B
Holdings as of
Jul 31, 2026
Last filed
Sep 22, 2026
CompanySharesValue as reported% of portfolioChangeAs of
Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN
38,060US$29M2.8%+13,569Jul 31, 2026
Universal Health Services, Inc.
NYSE:UHS
160KUS$26.9M2.6%+53,868Jul 31, 2026
Solventum Corporation
NYSE:SOLV
308KUS$26.3M2.5%+17,815Jul 31, 2026
Boston Scientific Corporation
NYSE:BSX
556KUS$26M2.5%+499KJul 31, 2026
Zimmer Biomet Holdings, Inc.
NYSE:ZBH
276KUS$25.9M2.5%+66,381Jul 31, 2026
Guardant Health, Inc.
NASDAQ:GH
158KUS$25.6M2.4%newJul 31, 2026
DaVita Inc.
NYSE:DVA
107KUS$25.6M2.4%−16,458Jul 31, 2026
Pfizer, Inc.
NYSE:PFE
986KUS$24.6M2.4%+446KJul 31, 2026
Tenet Healthcare Corporation
NYSE:THC
94,714US$24.1M2.3%+14,495Jul 31, 2026
The Cigna Group
NYSE:CI
86,083US$24M2.3%+15,145Jul 31, 2026
Globus Medical, Inc.
NYSE:GMED
300KUS$23.7M2.3%+80,730Jul 31, 2026
Medline Inc.
NASDAQ:MDLN
602KUS$23.6M2.3%+432KJul 31, 2026
Natera, Inc.
NASDAQ:NTRA
87,424US$23.4M2.2%+30,654Jul 31, 2026
Corcept Therapeutics Incorporated
NASDAQ:CORT
204KUS$23.3M2.2%newJul 31, 2026
Centene Corporation
NYSE:CNC
370KUS$23M2.2%newJul 31, 2026
Axsome Therapeutics, Inc.
NASDAQ:AXSM
96,954US$21.1M2.0%newJul 31, 2026
Encompass Health Corporation
NYSE:EHC
175KUS$19.5M1.9%+18,797Jul 31, 2026
Medtronic plc.
NYSE:MDT
227KUS$19.3M1.8%+95,474Jul 31, 2026
ResMed Inc.
NYSE:RMD
90,923US$19.2M1.8%+40,346Jul 31, 2026
Zoetis Inc.
NYSE:ZTS
247KUS$19.1M1.8%+183KJul 31, 2026
Qiagen N.V.
NYSE:QGEN
453KUS$18.8M1.8%+75,098Jul 31, 2026
Halozyme Therapeutics, Inc.
NASDAQ:HALO
226KUS$18.7M1.8%+109KJul 31, 2026
Incyte Corporation
NASDAQ:INCY
156KUS$18.7M1.8%−44,741Jul 31, 2026
Arrowhead Pharmaceuticals, Inc.
NASDAQ:ARWR
217KUS$18.4M1.8%newJul 31, 2026
Neurocrine Biosciences, Inc.
NASDAQ:NBIX
105KUS$17.5M1.7%+47,681Jul 31, 2026
Elevance Health, Inc.
NYSE:ELV
45,819US$17.2M1.6%−18,818Jul 31, 2026
Eli Lilly and Company
NYSE:LLY
14,775US$17M1.6%+6,546Jul 31, 2026
United Therapeutics Corporation
NASDAQ:UTHR
32,701US$16.9M1.6%+7,172Jul 31, 2026
Ascendis Pharma A/S
NASDAQ:ASND
66,435US$16.2M1.5%newJul 31, 2026
Bristol-Myers Squibb Company
NYSE:BMY
247KUS$16.1M1.5%+59,915Jul 31, 2026
Viatris Inc.
NASDAQ:VTRS
897KUS$15.7M1.5%newJul 31, 2026
Labcorp Holdings Inc.
NYSE:LH
50,851US$15.7M1.5%+8,298Jul 31, 2026
Quest Diagnostics Incorporated
NYSE:DGX
67,178US$15.7M1.5%+9,246Jul 31, 2026
Becton, Dickinson and Company
NYSE:BDX
94,088US$15.6M1.5%−2,191Jul 31, 2026
Medpace Holdings, Inc.
NASDAQ:MEDP
26,886US$15.5M1.5%+11,123Jul 31, 2026
STERIS plc (Ireland)
NYSE:STE
67,620US$15.4M1.5%+16,277Jul 31, 2026
GE HealthCare Technologies Inc.
NASDAQ:GEHC
222KUS$15.1M1.4%+62,938Jul 31, 2026
Gilead Sciences, Inc.
NASDAQ:GILD
113KUS$14.7M1.4%+31,236Jul 31, 2026
Doximity, Inc.
NYSE:DOCS
687KUS$14.4M1.4%newJul 31, 2026
Revolution Medicines, Inc.
NASDAQ:RVMD
76,029US$14.3M1.4%newJul 31, 2026
Exelixis, Inc.
NASDAQ:EXEL
262KUS$13.9M1.3%−179KJul 31, 2026
Biogen Inc.
NASDAQ:BIIB
65,899US$13.4M1.3%−37,317Jul 31, 2026
IQVIA Holdings, Inc.
NYSE:IQV
45,853US$10.8M1.0%+1,471Jul 31, 2026
Abbott Laboratories
NYSE:ABT
97,638US$10.3M0.98%+23,916Jul 31, 2026
Veeva Systems Inc.
NYSE:VEEV
49,923US$10.2M0.97%+29,725Jul 31, 2026
Thermo Fisher Scientific Inc
NYSE:TMO
17,671US$10.1M0.97%+2,273Jul 31, 2026
Chemed Corp
NYSE:CHE
19,021US$10.1M0.97%−21,055Jul 31, 2026
BridgeBio Pharma, Inc.
NASDAQ:BBIO
119KUS$9.53M0.91%newJul 31, 2026
Ionis Pharmaceuticals, Inc.
NASDAQ:IONS
180KUS$9.3M0.89%−22,024Jul 31, 2026
Agilent Technologies, Inc.
NYSE:A
66,697US$9.23M0.88%+291Jul 31, 2026
HCA Healthcare, Inc.
NYSE:HCA
22,725US$9.15M0.87%−17,260Jul 31, 2026
Henry Schein, Inc.
NASDAQ:HSIC
106KUS$9.1M0.87%−47,973Jul 31, 2026
Align Technology, Inc.
NASDAQ:ALGN
52,527US$8.89M0.85%+8,375Jul 31, 2026
Organon & Co.
NYSE:OGN
654KUS$8.87M0.85%−1.87MJul 31, 2026
AbbVie Inc.
NYSE:ABBV
35,205US$8.83M0.84%+18,892Jul 31, 2026
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
17,835US$8.51M0.81%+9,890Jul 31, 2026
Madrigal Pharmaceuticals, Inc.
NASDAQ:MDGL
16,500US$7.71M0.74%newJul 31, 2026
Tempus AI, Inc.
NASDAQ:TEM
153KUS$6.71M0.64%newJul 31, 2026
DexCom, Inc.
NASDAQ:DXCM
65,774US$5.49M0.52%+9,278Jul 31, 2026
Illumina, Inc.
NASDAQ:ILMN
25,195US$5.17M0.49%−66,915Jul 31, 2026
The Ensign Group, Inc.
NASDAQ:ENSG
27,632US$4.92M0.47%newJul 31, 2026
Bio-Rad Laboratories, Inc.
NYSE:BIO
15,085US$4.91M0.47%−52,798Jul 31, 2026
Amgen Inc.
NASDAQ:AMGN
12,232US$4.71M0.45%−30,793Jul 31, 2026
IDEXX Laboratories, Inc.
NASDAQ:IDXX
8,415US$4.7M0.45%+2,100Jul 31, 2026
BioMarin Pharmaceutical Inc.
NASDAQ:BMRN
77,415US$4.65M0.44%−56,573Jul 31, 2026
Envista Holdings Corporation
NYSE:NVST
168KUS$4.59M0.44%+28,264Jul 31, 2026
Stryker Corporation
NYSE:SYK
14,068US$4.58M0.44%+3,270Jul 31, 2026
Danaher Corporation
NYSE:DHR
23,256US$4.53M0.43%+4,543Jul 31, 2026
Merck & Company, Inc.
NYSE:MRK
34,473US$4.49M0.43%−91,373Jul 31, 2026
Revvity, Inc.
NYSE:RVTY
39,813US$4.48M0.43%−89,778Jul 31, 2026
Johnson & Johnson
NYSE:JNJ
17,444US$4.47M0.43%−13,521Jul 31, 2026
The Cooper Companies, Inc.
NASDAQ:COO
61,771US$4.47M0.43%−97,019Jul 31, 2026
West Pharmaceutical Services, Inc.
NYSE:WST
12,340US$4.21M0.40%−1,815Jul 31, 2026